An "age"-structured model of hematopoietic stem cell organization with application to chronic myeloid leukemia

Bulletin of Mathematical Biology

Volumn 71, Issue 3, 2009, Pages 602-626

  Roeder, Ingo ^a,b   Herberg, Maria ^a   Horn, Matthias ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Chronic myeloid leukemia; Computer simulation; Hematopoietic stem cell; Imatinib; Mathematical model; Partial differential equation

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; CHRONIC MYELOID LEUKEMIA; HEMATOPOIETIC STEM CELL; HUMAN; PATHOLOGY; STATISTICS;

HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MODELS, BIOLOGICAL; STOCHASTIC PROCESSES;

EID: 62149100742     PISSN: 00928240     EISSN: 15229602     Source Type: Journal    
DOI: 10.1007/s11538-008-9373-7     Document Type: Article

References (30)

1. Atkinson, K.A., 1989. An Introduction to Numerical Analysis, 2nd edn. Wiley, New York.
2. S. Branford T.P. Hughes Z. Rudzki 1999 Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics Br. J. Haematol. 107 3 587 599
3. E. Buchdunger J. Zimmermann H. Mett T. Meyer M. Müller B.J. Druker N.B. Lydon 1996 Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative Cancer Res. 56 1 100 104
4. C. Colijn M.C. Mackey 2005 A mathematical model of hematopoiesis: I. Periodic chronic myelogenous leukemia J. Theor. Biol. 237 2 117 132
5. D. Dingli F. Michor 2006 Successful therapy must eradicate cancer stem cells Stem Cells 24 12 2603 2610
6. d'Inverno, M., Luck, M., 2004. Understanding Agent Systems, 2nd edn. Springer, Berlin.
7. B.J. Druker S. Tamura E. Buchdunger S. Ohno G.M. Segal S. Fanning J. Zimmermann N.B. Lydon 1996 Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells Nat. Med. 2 5 561 566
8. I. Glauche M. Cross M. Loeffler I. Roeder 2007 Lineage specification of hematopoietic stem cells: mathematical modeling and biological implications Stem Cells 25 7 1791 1799
9. A. Hochhaus A. Weisser P. La Rosée M. Emig M.C. Müller S. Saussele A. Reiter C. Kuhn U. Berger R. Hehlmann N.C. Cross 2000 Detection and quantification of residual disease in chronic myelogenous leukemia Leukemia 14 6 998 1005
10. M. Holtz S.J. Forman R. Bhatia 2007 Growth factor stimulation reduces residual quiescent chronic myelogenous leukemia progenitors remaining after imatinib treatment Cancer Res. 67 3 1113 1120
11. M. Horn M. Loeffler I. Roeder 2008 Mathematical modeling of genesis and treatment of chronic myeloid leukemia Cells Tissues Organs 188 1-2 236 247
12. H.G. Jørgensen M. Copland E.K. Allan X. Jiang A. Eaves C. Eaves T. Holyoake 2006 Intermittent exposure of primitive quiescent chronic myeloid leukemia cells to granulocyte-colony stimulating factor in vitro promotes their elimination by imatinib mesylate Clin. Cancer Res. 12 2 626 633
13. P.S. Kim P.P. Lee D. Levy 2008 Modeling imatinib-treated chronic myelogenous leukemia: reducing the complexity of agent-based models Bull. Math. Biol. 70 3 728 744
14. P.S. Kim P.P. Lee D. Levy 2008 A PDE model for imatinib-treated chronic myelogenous leukemia Bull. Math. Biol. 10.1007/s11538-008-9336-z
15. LeVeque, R.J., 1990. Numerical Methods for Conservation Laws. Birkhäuser, Basel.
16. M. Loeffler I. Roeder 2002 Tissue stem cells: definition, plasticity, heterogeneity, self-organization and models-a conceptual approach Cells Tissues Organs 171 1 8 26
17. M.J. Mauro B.J. Druker 2001 Chronic myelogenous leukemia Curr. Opin. Oncol. 13 1 3 7
18. Metz, J.A.J., Diekmann, O., 1986. The Dynamics of Physiologically Structured Populations. Springer, Berlin.
19. F. Michor 2007 Reply: the long-term response to imatinib treatment of CML Br. J. Cancer 96 4 679 680
20. F. Michor T.P. Hughes Y. Iwasa S. Branford N.P. Shah C.L. Sawyers M.A. Nowak 2005 Dynamics of chronic myeloid leukaemia Nature 435 7046 1267 1270
21. Roeder, I., 2003. Dynamic Modeling of Hematopoietic Stem Cell Organization-Design and Validation of the New Concept of Within-Tissue Plasticity. Dissertation, University of Leipzig, ISSN: 1610-7233.
22. I. Roeder I. Glauche 2007 Pathogenesis, treatment effects, and resistance dynamics in chronic myeloid leukemia-insights from mathematical model analyses J. Mol. Med. 86 1 17 27
23. I. Roeder M. Loeffler 2002 A novel dynamic model of hematopoietic stem cell organization based on the concept of within-tissue plasticity Exp. Hematol. 30 8 853 861
24. I. Roeder R. Lorenz 2006 Asymmetry of stem cell fate and the potential impact of the niche: observations, simulations, and interpretations Stem Cell Rev. 2 3 171 180
25. I. Roeder L.M. Kamminga K. Braesel B. Dontje G. de Haan M. Loeffler 2005 Competitive clonal hematopoiesis in mouse chimeras explained by a stochastic model of stem cell organization Blood 105 2 609 616
26. I. Roeder M. Horn I. Glauche A. Hochhaus M.C. Mueller M. Loeffler 2006 Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications Nat. Med. 12 10 1181 1184
27. I. Roeder K. Braesel R. Lorenz M. Loeffler 2007 Stem cell fate analysis revisited: interpretation of individual clone dynamics in the light of a new paradigm of stem cell organization J. Biomed. Biotechnol. 2007 3 84656
28. D.G. Savage K.H. Antman 2002 Imatinib mesylate-a new oral targeted therapy N. Engl. J. Med. 346 9 683 693
29. J. Spanier K.B. Oldham 1987
30. P. Vigneri J.Y. Wang 2001 Induction of apoptosis in chronic myelogenous leukaemia cells through nuclear entrapment of BCR-ABL tyrosine kinase Nat. Med. 7 2 228 234